CEL-SCI director granted 110K options at $1.49

CEL-SCI Corp (CVM) director Bruno Jean-Marie Baillavoine reported a grant of 110,000 stock options on 2026-08-14.

Rhea-AI Filing Summary

CEL-SCI Corp (CVM) director Bruno Jean-Marie Baillavoine reported a grant of 110,000 stock options on 2026-08-14. The options have an exercise price of $1.49 per share, a nominal grant-date value of $0.01 per option, and expire on 2036-08-13. They vest in three equal annual installments commencing one year after the grant date. Following this grant, Baillavoine holds 138,021 options in total, all reported as directly owned.

Insider Trade Summary

Grant/Award: 110,000 shares

Grant/Award 1 txn

Insider BAILLAVOINE BRUNO JEAN-MARIE

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Options F1	110,000	$0.01	$1K

Holdings After Transaction: Options — 138,021 contracts (Direct)

Footnotes (1)

1. F1. The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Key Figures

Options granted: 110,000 options Exercise price: $1.49 per share Grant-date option value: $0.01 per option +2 more

5 metrics

Options granted 110,000 options Stock options granted to Bruno Jean-Marie Baillavoine on 2026-08-14

Exercise price $1.49 per share Exercise price for the 110,000 stock options

Grant-date option value $0.01 per option Transaction price per option on grant

Options after transaction 138,021 options Total options held by Baillavoine following the grant

Expiration date 2036-08-13 Expiration date of the granted stock options

Key Terms

stock options, exercise price, expiration date, vest

4 terms

stock options financial

"The stock options vest in three (3) equal annual installments"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

exercise price financial

"conversion_or_exercise_price": "1.4900""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date": "2036-08-13""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vest financial

"vest in three (3) equal annual installments commencing one year"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CEL-SCI Corp (CVM) disclose in this Form 4 for Bruno Jean-Marie Baillavoine?

The Form 4 reports a grant of 110,000 stock options to director Bruno Jean-Marie Baillavoine on 2026-08-14, with related exercise terms, vesting schedule, and updated total option holdings.

What are the key terms of the 110,000 options granted to the CVM director?

The options cover 110,000 shares of common stock at an exercise price of $1.49 per share, carry a grant-date value of $0.01 per option, and expire on 2036-08-13.

How do the new CEL-SCI (CVM) options for Baillavoine vest over time?

The 110,000 stock options vest in three equal annual installments, with vesting commencing one year after the grant date, meaning one-third each year over a three-year period.

How many CEL-SCI (CVM) options does Baillavoine hold after this transaction?

After the reported grant, Bruno Jean-Marie Baillavoine holds 138,021 options in total, all shown as directly owned according to the Form 4 data.

Is the reported CEL-SCI (CVM) Form 4 transaction a purchase or a grant?

The transaction is classified as a grant, award, or other acquisition of derivative securities (stock options), coded “A”, rather than an open-market purchase or sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 09:37 AM Accepted by SEC EDGAR 08/17/2026 - 09:37 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BAILLAVOINE BRUNO JEAN-MARIE

(Last) (First) (Middle)

8229 BOONE BLVD.

SUITE 802

(Street)

VIENNA VIRGINIA 22182

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options	$1.49	08/14/2026		A		110,000		(1)	08/13/2036	Common Stock	110,000	$0.01	138,021	D

Explanation of Responses:

1. The stock options vest in three (3) equal annual installments commencing one year after the grant date.

	Bruno Baillavoine	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)